74P Predicting the risk of immunotherapy-induced versus other-cause pneumonitis in stage IV non-small cell lung cancer (NSCLC) patients treated with immune checkpoint inhibitors

Autor: F. Tohidinezhad, L. Hendriks, A-M.C. Dingemans, J.G. Aerts, G. Bootsma, J.F. Vansteenkiste, S. Hashemi, E.F. Smit, H. Gietema, H.J. Aerts, A. Dekker, A. Traverso, D. De Ruysscher
Rok vydání: 2021
Předmět:
Zdroj: Annals of Oncology. 32:S1404
ISSN: 0923-7534
DOI: 10.1016/j.annonc.2021.10.092
Databáze: OpenAIRE